Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency. - Zhang CH; Spasov KA; Reilly RA; Hollander K; Stone EA; Ippolito JA; Liosi ME; Deshmukh MG; Tirado-Rives J; Zhang S; Liang Z; Miller SJ; et al. (ACS medicinal chemistry letters, 2021)